FibroGen competitors

FibroGen's competitors include Rigel Pharmaceuticals, XOMA, GlaxoSmithKline and RubrYc Therapeutics
Add company...
FibroGen
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
XOMA
XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology solutions company using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies.
Founding Date
Founding Date
1993
Founding Date
1996
Founding Date
1981
Founding Date
2000
Founding Date
2017
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
San Francisco, US HQ
Locations
South San Francisco, US HQ
Locations
Emeryville, US HQ
Locations
Brentford, GB HQ
Locations
San Ramon, US HQ
Employees
Employees
364
Employees
77
Employees
1878% decrease
Employees
98,462
Employees
N/A
Valuation ($)
Valuation ($)
5.4 b
Valuation ($)
453.1 m
Valuation ($)
201.9 m
Valuation ($)
101.9 b
Valuation ($)
N/A
Facebook likes
Facebook likes
68
Facebook likes
1.1 k
Facebook likes
N/A
Facebook likes
273 k
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
185
Twitter followers
163.4 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$125.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$52.7m (FY, 2017)
Revenue (est.)
£30.2b (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($126.2m) (FY, 2017)
Net income
($78m) (FY, 2017)
Net income
N/A
Net income
£2.2b (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 130m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 10m
For sources of this data, please see the company profileDownload Excel

View company profiles

Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
77

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

View company
XOMA
HQ
Emeryville, US
Employees
18

XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company
RubrYc Therapeutics
HQ
San Ramon, US

RubrYc Therapeutics is a biotechnology solutions company using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies.

View company